Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral Neuropathy

Clinical trial NCT06495424 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06495424
Sponsor: Averitas Pharma, Inc.
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Peripheral Diabetic Neuropathy Painful Diabetic Neuropathy

Start date: 2025-03-14
Primary completion: 2027-03-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.